External Validation of the COVID-NoLab and COVID-SimpleLab Prognostic Tools.

MedStar author(s):
Citation: Annals of Family Medicine. 20(6):548-550, 2022 Nov-Dec.PMID: 36443081Institution: MedStar Washington Hospital CenterDepartment: Emergency MedicineForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *COVID-19 | Canada/ep [Epidemiology] | Humans | Inpatients | Outpatients | PrognosisYear: 2022Local holdings: Available online through MWHC library: May 2003 - presentISSN:
  • 1544-1709
Name of journal: Annals of family medicineAbstract: Our objective was to externally validate 2 simple risk scores for mortality among a mostly inpatient population with COVID-19 in Canada (588 patients for COVID-NoLab and 479 patients for COVID-SimpleLab). The mortality rates in the low-, moderate-, and high-risk groups for COVID-NoLab were 1.1%, 9.6%, and 21.2%, respectively. The mortality rates for COVID-SimpleLab were 0.0%, 9.8%, and 20.0%, respectively. These values were similar to those in the original derivation cohort. The 2 simple risk scores, now successfully externally validated, offer clinicians a reliable way to quickly identify low-risk inpatients who could potentially be managed as outpatients in the event of a bed shortage. Both are available online (https://ebell-projects.shinyapps.io/covid_nolab/ and https://ebell-projects.shinyapps.io/COVID-SimpleLab/). Copyright © 2022 Annals of Family Medicine, Inc.All authors: Barrett B, Cai X, Dong H, Ebell MH, Goyal M, Krist AH, Lennon RP, Mainous AG 3rd, Tarn DM, Tuan WJ, Zgierska AEFiscal year: FY2023Digital Object Identifier: Date added to catalog: 2022-12-13
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 36443081 Available 36443081

Available online through MWHC library: May 2003 - present

Our objective was to externally validate 2 simple risk scores for mortality among a mostly inpatient population with COVID-19 in Canada (588 patients for COVID-NoLab and 479 patients for COVID-SimpleLab). The mortality rates in the low-, moderate-, and high-risk groups for COVID-NoLab were 1.1%, 9.6%, and 21.2%, respectively. The mortality rates for COVID-SimpleLab were 0.0%, 9.8%, and 20.0%, respectively. These values were similar to those in the original derivation cohort. The 2 simple risk scores, now successfully externally validated, offer clinicians a reliable way to quickly identify low-risk inpatients who could potentially be managed as outpatients in the event of a bed shortage. Both are available online (https://ebell-projects.shinyapps.io/covid_nolab/ and https://ebell-projects.shinyapps.io/COVID-SimpleLab/). Copyright © 2022 Annals of Family Medicine, Inc.

English

Powered by Koha